semaglutide side effects kidney Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management FLOWing with the SemagluTIDE —

A recent Washington Post

Offer supports access for eligible patients without insurance to FDA-approved Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg, the GLP-1 medicine with...

coupon codes, promo codes, and discount codes

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity

But while these medications are game-changers, what you eat still matters a lot.

These worries are valid and deserve a clear, clinical explanation